INC Research Holdings, Inc. (NASDAQ:INCR) CEO Alistair Macdonald sold 8,828 shares of INC Research Holdings stock in a transaction on Thursday, August 17th. The stock was sold at an average price of $55.65, for a total transaction of $491,278.20. Following the transaction, the chief executive officer now directly owns 110,629 shares in the company, valued at $6,156,503.85. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.
Alistair Macdonald also recently made the following trade(s):
- On Monday, July 3rd, Alistair Macdonald sold 10,555 shares of INC Research Holdings stock. The stock was sold at an average price of $58.38, for a total transaction of $616,200.90.
INC Research Holdings, Inc. (INCR) opened at 56.25 on Tuesday. The company has a 50 day moving average of $56.31 and a 200-day moving average of $52.08. INC Research Holdings, Inc. has a one year low of $40.65 and a one year high of $61.10. The stock has a market capitalization of $3.05 billion, a P/E ratio of 34.47 and a beta of 1.42.
INC Research Holdings (NASDAQ:INCR) last announced its earnings results on Thursday, July 27th. The company reported $0.64 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.64. INC Research Holdings had a return on equity of 40.69% and a net margin of 5.69%. The business had revenue of $258.10 million for the quarter, compared to analysts’ expectations of $256.76 million. During the same period last year, the firm posted $0.61 earnings per share. The business’s revenue for the quarter was down .3% on a year-over-year basis. Equities research analysts predict that INC Research Holdings, Inc. will post $2.61 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY WARNING: This piece of content was posted by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of United States & international copyright and trademark laws. The legal version of this piece of content can be read at https://sportsperspectives.com/2017/08/22/inc-research-holdings-inc-incr-ceo-alistair-macdonald-sells-8828-shares-of-stock.html.
A number of hedge funds have recently modified their holdings of INCR. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of INC Research Holdings by 14.8% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,765 shares of the company’s stock valued at $103,000 after buying an additional 228 shares during the period. Pacad Investment Ltd. purchased a new stake in INC Research Holdings during the second quarter worth about $123,000. Riverhead Capital Management LLC purchased a new stake in INC Research Holdings during the second quarter worth about $128,000. Victory Capital Management Inc. increased its stake in INC Research Holdings by 17.6% in the second quarter. Victory Capital Management Inc. now owns 2,377 shares of the company’s stock worth $139,000 after buying an additional 356 shares during the last quarter. Finally, Invictus RG purchased a new stake in INC Research Holdings during the first quarter worth about $115,000. 99.84% of the stock is currently owned by institutional investors.
A number of equities analysts have issued reports on the stock. Goldman Sachs Group, Inc. (The) reaffirmed a “buy” rating and set a $65.00 price objective on shares of INC Research Holdings in a report on Monday, August 7th. TheStreet downgraded shares of INC Research Holdings from a “b” rating to a “c” rating in a report on Friday, July 28th. Jefferies Group LLC reaffirmed a “hold” rating and set a $62.50 price objective on shares of INC Research Holdings in a report on Sunday, July 30th. BidaskClub downgraded shares of INC Research Holdings from a “strong-buy” rating to a “buy” rating in a report on Monday, July 24th. Finally, William Blair downgraded shares of INC Research Holdings from an “outperform” rating to a “market perform” rating in a report on Tuesday, June 20th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and five have issued a buy rating to the company’s stock. INC Research Holdings presently has a consensus rating of “Hold” and a consensus price target of $63.79.
About INC Research Holdings
INC Research Holdings, Inc is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services.
Receive News & Ratings for INC Research Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INC Research Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.